The response is initially non-specific, receptor independent and cytokine-mediated (i.e., IFN gamma) that triggers tumor antigen release, and/or converts a “cold” tumor into a “hot” tumor type with the newly expanded CTL infiltration. This evidence concerns the gene IFNG and neoplasm.